Acute renal and neurotoxicity due to weight-based dosing of intravenous acyclovir: How to dose in obese patients?
Background: Acyclovir is a hydrophilic drug that is mainly distributed in the lean compartments of the body. Consequently, dosing on total body weight in obese patients may lead to drug overdosing. Inconsistency in clinical guideline recommendations and a lack of clear recommendations in the Summary...
Main Authors: | Bastiaan TGM Sallevelt, Erin H Smeijsters, Toine CG Egberts, Kim CM van der Elst, Tania Mudrikova |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-10-01
|
Series: | Clinical Infection in Practice |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590170220300339 |
Similar Items
-
Vitreous pharmacokinetics and electroretinographic findings after intravitreal injection of acyclovir in rabbits
by: Francisco Max Damico, et al.
Published: (2012-08-01) -
Development of solid lipid nanoparticles for oral delivery of acyclovir and evaluation of its pharmacokinetics profile
by: Hassan, Haniza
Published: (2018) -
Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients
by: Natalia Maximova, et al.
Published: (2022-04-01) -
Incidence, patterns, risk factors and clinical outcomes of intravenous acyclovir induced nephrotoxicity
by: Abdullah M. Al-Alawi, et al.
Published: (2022-06-01) -
SEARCH OF INHIBITORS OF HERPES VIRAL REPLICATION: 30 YEARS AFTER ACYCLOVIR
by: Korovina A. N., et al.
Published: (2013-08-01)